Ligand Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
Amgen USD 3.11B 198M 2024-12
Baxter International USD 1.74B 73M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Glaxosmithkline GBP 2.52B 199M 2024-12
Insmed USD 26.15M 4.98M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
Ligand Pharmaceuticals USD 2.84M 388K 2024-12
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 3.71B 181M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Pfizer USD 5.65B 781M 2024-12
Veracyte USD 39.88M 3.03M 2024-12



Ligand Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.